Targeted high throughput sequencing of a cancer-related exome subset by specific sequence capture with a fully automated microarray platform - PubMed (original) (raw)
Targeted high throughput sequencing of a cancer-related exome subset by specific sequence capture with a fully automated microarray platform
Daniel Summerer et al. Genomics. 2010 Apr.
Free article
Abstract
Sequence capture methods for targeted next generation sequencing promise to massively reduce cost of genomics projects compared to untargeted sequencing. However, evaluated capture methods specifically dedicated to biologically relevant genomic regions are rare. Whole exome capture has been shown to be a powerful tool to discover the genetic origin of disease and provides a reduction in target size and thus calculative sequencing capacity of >90-fold compared to untargeted whole genome sequencing. For further cost reduction, a valuable complementing approach is the analysis of smaller, relevant gene subsets but involving large cohorts of samples. However, effective adjustment of target sizes and sample numbers is hampered by the limited scalability of enrichment systems. We report a highly scalable and automated method to capture a 480 Kb exome subset of 115 cancer-related genes using microfluidic DNA arrays. The arrays are adaptable from 125 Kb to 1 Mb target size and/or one to eight samples without barcoding strategies, representing a further 26 - 270-fold reduction of calculative sequencing capacity compared to whole exome sequencing. Illumina GAII analysis of a HapMap genome enriched for this exome subset revealed a completeness of >96%. Uniformity was such that >68% of exons had at least half the median depth of coverage. An analysis of reference SNPs revealed a sensitivity of up to 93% and a specificity of 98.2% or higher.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
- High-performance single-chip exon capture allows accurate whole exome sequencing using the Illumina Genome Analyzer.
Jiang T, Yang L, Jiang H, Tian G, Zhang X. Jiang T, et al. Sci China Life Sci. 2011 Oct;54(10):945-52. doi: 10.1007/s11427-011-4232-4. Epub 2011 Oct 29. Sci China Life Sci. 2011. PMID: 22038007 - Massively parallel sequencing of ataxia genes after array-based enrichment.
Hoischen A, Gilissen C, Arts P, Wieskamp N, van der Vliet W, Vermeer S, Steehouwer M, de Vries P, Meijer R, Seiqueros J, Knoers NV, Buckley MF, Scheffer H, Veltman JA. Hoischen A, et al. Hum Mutat. 2010 Apr;31(4):494-9. doi: 10.1002/humu.21221. Hum Mutat. 2010. PMID: 20151403 - Multiplex amplification of large sets of human exons.
Porreca GJ, Zhang K, Li JB, Xie B, Austin D, Vassallo SL, LeProust EM, Peck BJ, Emig CJ, Dahl F, Gao Y, Church GM, Shendure J. Porreca GJ, et al. Nat Methods. 2007 Nov;4(11):931-6. doi: 10.1038/nmeth1110. Epub 2007 Oct 14. Nat Methods. 2007. PMID: 17934468 - Enabling technologies of genomic-scale sequence enrichment for targeted high-throughput sequencing.
Summerer D. Summerer D. Genomics. 2009 Dec;94(6):363-8. doi: 10.1016/j.ygeno.2009.08.012. Epub 2009 Aug 29. Genomics. 2009. PMID: 19720138 Review. - Advantages of next-generation sequencing versus the microarray in epigenetic research.
Hurd PJ, Nelson CJ. Hurd PJ, et al. Brief Funct Genomic Proteomic. 2009 May;8(3):174-83. doi: 10.1093/bfgp/elp013. Epub 2009 Jun 17. Brief Funct Genomic Proteomic. 2009. PMID: 19535508 Review.
Cited by
- Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.
Cunha KS, Oliveira NS, Fausto AK, de Souza CC, Gros A, Bandres T, Idrissi Y, Merlio JP, de Moura Neto RS, Silva R, Geller M, Cappellen D. Cunha KS, et al. Genes (Basel). 2016 Dec 17;7(12):133. doi: 10.3390/genes7120133. Genes (Basel). 2016. PMID: 27999334 Free PMC article. - Drug discovery in advanced prostate cancer: translating biology into therapy.
Yap TA, Smith AD, Ferraldeschi R, Al-Lazikani B, Workman P, de Bono JS. Yap TA, et al. Nat Rev Drug Discov. 2016 Oct;15(10):699-718. doi: 10.1038/nrd.2016.120. Epub 2016 Jul 22. Nat Rev Drug Discov. 2016. PMID: 27444228 Review. - The minimal amount of starting DNA for Agilent's hybrid capture-based targeted massively parallel sequencing.
Chung J, Son DS, Jeon HJ, Kim KM, Park G, Ryu GH, Park WY, Park D. Chung J, et al. Sci Rep. 2016 May 25;6:26732. doi: 10.1038/srep26732. Sci Rep. 2016. PMID: 27220682 Free PMC article. - Strategies for modern biomarker and drug development in oncology.
Smith AD, Roda D, Yap TA. Smith AD, et al. J Hematol Oncol. 2014 Oct 3;7:70. doi: 10.1186/s13045-014-0070-8. J Hematol Oncol. 2014. PMID: 25277503 Free PMC article. Review. - Comprehensive molecular diagnosis of Bardet-Biedl syndrome by high-throughput targeted exome sequencing.
Xing DJ, Zhang HX, Huang N, Wu KC, Huang XF, Huang F, Tong Y, Pang CP, Qu J, Jin ZB. Xing DJ, et al. PLoS One. 2014 Mar 7;9(3):e90599. doi: 10.1371/journal.pone.0090599. eCollection 2014. PLoS One. 2014. PMID: 24608809 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous